• Annexin V-PE Reagent for CD38 CAR-T Assays

  2026-08-23

  Use Annexin V-PE Reagent to separate early target-cell apoptosis from CAR-T fratricide during CD38 binder optimization. Its calcium-dependent phosphatidylserine readout supports rapid flow cytometry and microscopy workflows that complement structural, binding, and cytotoxicity measurements.

• Epoxomicin in Proteasome Pathway Research

  2026-08-22

  Epoxomicin is an irreversible proteasome inhibitor for connecting protein turnover with inflammation, viral pathogenesis, and disease-relevant cell biology. This guide translates its covalent mechanism into practical degradation assays, RIPK3-focused workflows, and troubleshooting strategies.

• HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-08-21

  Build sensitive red-channel detection into immunofluorescence, tissue staining, flow cytometry, and ELISA workflows with a goat anti-rabbit IgG secondary antibody designed for rabbit primary antibodies. Its 590 nm excitation and 617 nm emission support multiplex imaging and quantitative assays, while application-specific titration helps control background in complex neuroblastoma models.

• Fe3O4@ZIF-8 for Jaw Osteomyelitis: Study Insights

  2026-08-21

  The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a coordinated antibacterial and bone-regenerative platform for jaw osteomyelitis. Its central innovation is the combination of pH-responsive Zn2+ release, bacterial stress-response disruption, Fe3O4 superparamagnetism, and static magnetic field support for infected bone repair.

• Sumatriptan Succinate: From Biology to Translation

  2026-08-20

  Sumatriptan is more than an established migraine therapy: it is a strategically useful 5-HT1 receptor agonist for connecting receptor pharmacology, CGRP biology, neurogenic inflammation, and care-pathway design. This article outlines experimental workflows, translational boundaries, and how to interpret pediatric emergency evidence without overstating what a research compound can prove.

• PR-619: Practical DUB Inhibition Workflows

  2026-08-20

  PR-619 is a reversible, cell-permeable deubiquitylating enzymes inhibitor for tracking ubiquitin accumulation without directly blocking proteasomal catalytic activity. This guide translates its chemistry into reproducible workflows for ubiquitination pathway research, autophagy activation assays, cancer biology research, and neurodegenerative disease models.

• Valemetostat (DS-3201) in Lymphoma Research

  2026-08-19

  Valemetostat, also known as DS-3201, gives lymphoma researchers a practical way to test potent EZH2 suppression across wild-type and recurrent mutant backgrounds while examining the biological rationale for EZH1/2 co-targeting. This guide connects enzyme potency with cell-based epigenetic readouts, mutation-aware dose design, and troubleshooting for reproducible lymphoma assays.

• EZ Cap™ Firefly Luciferase mRNA: Assay Design

  2026-08-18

  EZ Cap™ Firefly Luciferase mRNA can function as more than a bioluminescent endpoint: it is a practical probe of delivery, translation, cellular energy, and assay stability. This guide connects Cap1/poly(A) engineering with storage decisions and the latest trehalose-loaded LNP evidence.

• Mc-Val-Cit-PABC-PNP Workflow Guide

  2026-08-18

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker intended to support lysosome-triggered payload release in antibody-drug conjugate research. It is suitable for controlled, organic-solvent-based workflows but is insoluble in water and ethanol, not recommended for long-term solution storage, and not intended for diagnostic, clinical, or therapeutic use.

• Foretinib: From Kinase Potency to Assay Meaning

  2026-08-17

  Foretinib and GSK1363089 research often emphasizes kinase potency, but meaningful interpretation requires separating growth arrest, cell death, and motility. This guide develops an assay-centered framework for tumor cell growth inhibition, metastatic behavior, and translational model selection.

• LGK-974: Reliable PORCN Inhibition in Wnt Assays

  2026-08-17

  This scenario-driven guide explains how LGK-974 (Porcupine Inhibitor), SKU B2307, can improve interpretation and reproducibility in Wnt-dependent viability, proliferation, and cytotoxicity assays. It connects mechanism, dosing, solvent handling, controls, and vendor selection to practical laboratory decisions.

• SC 79: Akt Signaling From Stroke to Cancer

  2026-08-16

  SC 79 offers a mechanistically distinctive way to activate cytosolic Akt, linking neuroprotection research with emerging cancer ferroptosis studies and a more rigorous translational strategy.

• Genotyping Kit: From Sample to Allele Call

  2026-08-15

  The Genotyping Kit for target alleles streamlines PCR-ready DNA preparation from tissues, insects, fishes, and cells. This article connects rapid genotyping with assay decisions inspired by NR1I3–E-cadherin research in experimental colitis.

• BCECF-AM for Secretory Pathway pH Mapping

  2026-08-15

  BCECF-AM enables ratiometric intracellular pH measurement with strong relevance to live-cell studies of secretion, trafficking, and stress. This article shows how to interpret cytosolic pH changes in plant and mammalian systems without confusing a global cellular readout with organelle-specific acidification.

• GS-4997 Halts Tubulointerstitial Injury in Lupus Nephritis

  2026-08-14

  A 2024 FASEB Journal study identifies ASK1 signaling as a pharmacologically tractable driver of tubulointerstitial injury in lupus nephritis. In lupus-prone mice and LPS-stimulated renal tubular cells, GS-4997 reduced inflammation, fibrosis, renal injury, and downstream p38/JNK activation, supporting further investigation of ASK1-directed mechanisms in renal disease.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page